MLTX - CIK 0001821586
The table below shows MoonLake Immunotherapeutics's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $334.52M | $180.43M | $451.17M | $39.51M | $666.79K | $1.34M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $421.69M |
| $474.29M |
| $514.17M |
| $76.51M |
| $793.71K |
| $1.62M |
| Property, plant & equipment | $577.00K | $722.23K | $320.87K | $49.39K | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $424.43M | $477.93M | $526.54M | $76.84M | $115.84M | $116.63M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $45.48M | $22.46M | $9.97M | $7.67M | $3.87M | $125.18K |
| Long-term debt | $74.10M | - | - | - | - | - |
| Total liabilities | $119.95M | $24.54M | $13.05M | $8.08M | $7.90M | $4.15M |
| Retained earnings | -$462.91M | -$235.59M | -$116.66M | -$80.65M | -$7.06M | -$90.84K |
| Total equity | $304.48M | $446.83M | $495.68M | $48.90M | -$7.06M | $5.00M |